In short, RBM15‐mediated m6A modification enhanced SRSF1 stability, and SRSF1 promoted ATP7B alternative splicing to inhibit cuproptosis, thereby promoting NSCLC cell proliferation and tumor growth. This evidence concerns the gene SRSF1 and neoplasm.